11 September 2015

New implant captures cancer cells in mice

A tiny implant has been developed that captures tumour cells in the bloodstream to prevent spreading of cancer through the body.


Scientists in the United States said they had created a tiny implant which, in mice for now, captures cancer cells spreading through the body.

Cells moving from the original cancer site to infect other organs in a stealthy process called metastasis are usually detected too late to save a patient's life.

Cancer cells hard to spot

The early detection of circulating tumour cells, or CTCs, in the bloodstream can speed up diagnosis and life-saving treatment.

Read: Treating cancer

But these wandering cancer cells travel in very small numbers, often for long periods of time, before settling in a new site, and are thus very hard to spot.

The study, published in the journal Nature Communication, suggests that capturing CTCs would prevent their spread and help halt disease progression.

"Animals receiving an implant had a significantly reduced burden of disease in their lungs relative to animals that did not have an implant," study co-author Lonnie Shea at Northwestern University in Illinois told AFP.

In experiments, Shea and a team built biodegradable disks about half-a-centimetre (0.2 inches) wide, and implanted two per mouse.

The implant which used immune cells as bait also contained a scanner to detect the presence of trapped cells.

"The combined systems can enable the early detection of metastatic disease," Shea said by email.

Read: Technology may hold the key to fighting cancer

"The initial benefit is detection catching the metastasis before it spreads widely throughout the body," he explained.

Colonising organs

"However... the opportunity to reduce burden (of cell spread) can potentially extend the period of time over which therapies may be effective."

As a bonus, the implant collected metastasised cancer cells for analysis, making it easier to identify the best treatment.

There was no reason to believe the results achieved in lab mice could not be replicated in humans, said Shea.

"The main idea of cells colonising organs is the same between mice and humans, and while some of the details may change, we think we can build that into the design of our implant."

Shea said he hoped clinical trials with human cancer sufferers could begin soon.

Read more:

Brachytherapy significantly improves survival rates for those with cervical cancer

Killer T-cell therapy shows promise against leukaemia

Scientists turn to aspirin to turbo-charge cancer immunotherapy

Image: Dividing cancer cells from iStock


Read Health24’s Comments Policy

Comment on this story
Comments have been closed for this article.

Ask the Expert

Cancer expert

CANSA’s purpose is to lead the fight against cancer in South Africa. Its mission is to be the preferred non-profit organisation that enables research, educates the public and provides support to all people affected by cancer. Questions are answered by CANSA’s Head of Health Professor Michael Herbst and Head of Advocacy Magdalene Seguin. For more information, visit

Still have a question?

Get free advice from our panel of experts

The information provided does not constitute a diagnosis of your condition. You should consult a medical practitioner or other appropriate health care professional for a physical exmanication, diagnosis and formal advice. Health24 and the expert accept no responsibility or liability for any damage or personal harm you may suffer resulting from making use of this content.

* You must accept our condition

Forum Rules